These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7509816

  • 1. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice.
    Kitamura Y, Itano Y, Kubo T, Nomura Y.
    J Neuroimmunol; 1994 Mar; 50(2):221-4. PubMed ID: 7509816
    [Abstract] [Full Text] [Related]

  • 2. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM, Murphy DL.
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [Abstract] [Full Text] [Related]

  • 3. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Date I, Felten DL, Felten SY.
    Brain Res; 1990 Jun 11; 519(1-2):266-76. PubMed ID: 1975765
    [Abstract] [Full Text] [Related]

  • 4. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug 11; 22(4):213-5, 253. PubMed ID: 2575971
    [Abstract] [Full Text] [Related]

  • 5. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P, Langston JW, Di Monte DA.
    J Pharmacol Exp Ther; 1993 Dec 11; 267(3):1515-20. PubMed ID: 8263813
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 7. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.
    Marien M, Briley M, Colpaert F.
    Eur J Pharmacol; 1993 Jun 04; 236(3):487-9. PubMed ID: 7689466
    [Abstract] [Full Text] [Related]

  • 8. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov 04; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 9. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F, Leng A, Mura A, Bettinetti L, Feldon J, Gmeiner P, Ferger B.
    Biochem Pharmacol; 2003 Sep 15; 66(6):1025-32. PubMed ID: 12963489
    [Abstract] [Full Text] [Related]

  • 10. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
    Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):179-81. PubMed ID: 3876943
    [Abstract] [Full Text] [Related]

  • 11. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T.
    Neurol Res; 2002 Oct 08; 24(7):655-62. PubMed ID: 12392201
    [Abstract] [Full Text] [Related]

  • 12. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 13. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
    Date I, Felten SY, Felten DL.
    Neurosci Lett; 1989 Dec 04; 106(3):282-6. PubMed ID: 2601883
    [Abstract] [Full Text] [Related]

  • 14. Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.
    Melamed E, Rosenthal J, Cohen O, Uzzan A, Globus M.
    Neuropharmacology; 1985 Sep 04; 24(9):923-5. PubMed ID: 3877249
    [Abstract] [Full Text] [Related]

  • 15. Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats.
    Tsai YF, Tsai HW, Tai MY.
    Neurosci Res; 1994 Jul 04; 20(1):27-33. PubMed ID: 7984338
    [Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 04; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 17. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA, Langston JW, DeLanney LE, Irwin I, Brooks JD.
    Neurosci Lett; 1985 Sep 06; 59(3):259-64. PubMed ID: 3932903
    [Abstract] [Full Text] [Related]

  • 18. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ.
    J Neuroimmunol; 2005 Jan 06; 158(1-2):14-25. PubMed ID: 15589033
    [Abstract] [Full Text] [Related]

  • 19. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS, Trobough KL, Crampton JM, Wilson JA.
    Gen Pharmacol; 1990 Jan 06; 21(2):181-7. PubMed ID: 2332138
    [Abstract] [Full Text] [Related]

  • 20. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 06; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.